Obsidian Therapeutics to Present at Upcoming Investor Conferences

Retrieved on: 2018-03-18 20:22:30

Tags for this article:

Cambridge

Atlas Venture

Gilman

Obsidian Therapeutics Inc.

Click the tags to see associated articles and topics

Obsidian Therapeutics to Present at Upcoming Investor Conferences. View article details on hiswai:

Excerpt

<div>... Thomas Wandless, a leading researcher in chemical and systems biology, Obsidian's lead programs are CAR-T products that incorporate controllable functions for enhanced safety and efficacy. Obsidian was founded in 2015 by <b>Atlas Venture</b> and is funded by a strong syndicate of venture investors.</div>

Article found on:

View Original Article